Company
Lantern Pharma
- Business model
- B2B
Record updated 28 September 2026
About
(NASDAQ: LTRN) is a clinical stage biopharmaceutical company innovating the repurposing, revitalization and development of precision therapeutics in oncology. Lantern leverages advances in machine learning, genomics and artificial intelligence to discover biomarker signatures that help identify patients more likely to respond to our pipeline of cancer therapeutics.